Turkish Validity and Reliability Study of the "Sexual Health Care Questionnaire"

May 31, 2023 updated by: CEYDA SU GUNDUZ, Marmara University

Turkish Validity and Reliability Study of the "Sexual Health Care Questionnaire" for Nursing Students

Determining the knowledge, attitudes and self-efficacy of nursing students in the field of sexual health care is important for the development and planning of nursing education and research. There is no Turkish tool in the literature that will enable a comprehensive assessment of nursing students' knowledge, attitudes and self-efficacy towards sexual health care. The aim of the study is to determine the validity and reliability of the Turkish version of the three scales (knowledge, attitude, self-efficacy) in the "Sexual Healthcare Questionnaire" for nursing students. This is a methodological study. These scales translated into Turkish language. Data will be collected in April 2023 through an online questionnaire from nursing students at a public university in Turkey. The test-retest will be performed again after 4 weeks. At least 310 participants from 2nd and 3rd year nursing students will be included in the study.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Sexuality is an indispensable part of being human, affecting the lives of individuals. It is necessary to provide sexual health services to support the quality of life of individuals who have problems with sexual health. In addition to being in a unique position in the field of practice to provide sexual health care, nurses' service on sexual issues is an important professional responsibility in order to provide holistic care. Determining the knowledge, attitudes and self-efficacy of nursing students in the field of sexual health care is important for the development and planning of nursing education and research. There is no Turkish tool in the literature that will enable a comprehensive assessment of nursing students' knowledge, attitudes and self-efficacy towards sexual health care. The aim of the study is to determine the validity and reliability of the Turkish version of the three scales (knowledge, attitude, self-efficacy) in the "Sexual Healthcare Questionnaire" for nursing students. This is a methodological study. These scales translated into Turkish language. Data will be collected in April 2023 through an online questionnaire from nursing students at a public university in Turkey. The test-retest will be performed again after 4 weeks. At least 310 participants from 2nd and 3rd year nursing students will be included in the study.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
310

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

At least 310 students should form the sample size, which is 10 times the "Knowledge of Sexual Healthcare Scale", which has the highest number of items with 31 items among the scales in our survey.

Description

Inclusion Criteria:

  • Being a 2nd or 3rd year nursing student
  • Absence of psychiatric illness
  • Being willing to participate

Exclusion Criteria:

  • Desire to leave the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Student Group
Three scales (knowledge, attitude, self-efficacy) in the "Sexual Healthcare Questionnaire" will be applied to 2nd and 3rd year nursing students. The scales will be re-administered to at least 30 students within 4 weeks.
Other: Student Group
"Sexual Healthcare Questionnaire" will be applied to nursing students to adapt it to Turkish.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Attitude to Sexual Healthcare Scale
Time Frame: baseline
The scale determines the attitudes of nursing students towards sexual health services. The scale consists of 3 sub-dimensions and a total of 18 questions. Each item on the 5-point Likert scale is rated as 5 = strongly agree, 4 = agree, 3 = undecided, 2 = disagree, and 1 = strongly disagree. The scores that can be obtained from the scale vary between 18 and 90.
baseline
Self-Efficacy for Sexual Healthcare Scale
Time Frame: baseline
The scale measures nursing students' self-efficacy in providing sexual health services. The scale consists of 3 sub-dimensions and a total of 22 items. Each item is rated on a 5-point Likert scale ranging from 1= strongly disagree, 2= disagree, 3= undecided, 4= agree, 5= strongly agree. The total score ranges from 22 to 110 points.
baseline
Knowledge of Sexual Healthcare Scale
Time Frame: baseline
The scale was designed to measure the knowledge of nursing students about sexual health care. The scale consists of 31 items. Each item was rated as "yes", "no" and "don't know". 1 point is given for the correct answer, 0 points for the wrong answer and the answer I don't know. A score between 0-31 can be obtained from the scale.
baseline
Knowledge of Sexual Healthcare Scale
Time Frame: Retest (later 4 weeks)
The scale was designed to measure the knowledge of nursing students about sexual health care. The scale consists of 31 items. Each item was rated as "yes", "no" and "don't know". 1 point is given for the correct answer, 0 points for the wrong answer and the answer I don't know. A score between 0-31 can be obtained from the scale.
Retest (later 4 weeks)
Attitude to Sexual Healthcare Scale
Time Frame: Retest (later 4 weeks)
The scale determines the attitudes of nursing students towards sexual health services. The scale consists of 3 sub-dimensions and a total of 18 questions. Each item on the 5-point Likert scale is rated as 5 = strongly agree, 4 = agree, 3 = undecided, 2 = disagree, and 1 = strongly disagree. The scores that can be obtained from the scale vary between 18 and 90.
Retest (later 4 weeks)
Self-Efficacy for Sexual Healthcare Scale
Time Frame: Retest (later 4 weeks)
The scale measures nursing students' self-efficacy in providing sexual health services. The scale consists of 3 sub-dimensions and a total of 22 items. Each item is rated on a 5-point Likert scale ranging from 1= strongly disagree, 2= disagree, 3= undecided, 4= agree, 5= strongly agree. The total score ranges from 22 to 110 points.
Retest (later 4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Marmara University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Nurdan Demirci, Prof., Marmara University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 28, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 7, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 31, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 1, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 1, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 31, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • marmaraceydasugunduzistanbul

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings